Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

The proteasome inhibitor VELCADE reduces infarction in rat models of focal cerebral ischemia.

Henninger N, Sicard KM, Bouley J, Fisher M, Stagliano NE. The proteasome inhibitor VELCADE reduces infarction in rat models of focal cerebral ischemia. Neurosci Lett. 2006 May 08; 398(3):300-5.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.